Description
Product Overview: 5-Amino-1MQ (5-Amino)
5-Amino-1MQ (5-Amino-1-methylquinolinium) is a selective, membrane-permeable small-molecule inhibitor of the enzyme Nicotinamide N-methyltransferase (NNMT). NNMT is a key cytosolic enzyme predominant in adipose tissue and the liver that catalyzes the methylation of nicotinamide using S-adenosylmethionine (SAM) as a methyl donor. By blocking NNMT activity, 5-Amino-1MQ prevents the depletion of intracellular NAD+ and SAM, offering a novel research pathway for investigating fat cell metabolism, cellular energy expenditure, and anti-aging signaling mechanisms.
Primary Research Applications & Reasons for Study
- NNMT Enzyme Inhibition: Selectively blocking NNMT to prevent the wasteful breakdown of nicotinamide into 1-methylnicotinamide (1-MNA).
- Intracellular NAD+ & SAM Preservation: Maintaining robust cellular pools of NAD+ and S-adenosylmethionine (SAM) to fuel sirtuin activity and histone/DNA methylation processes.
- Adipocyte Shrinkage & Metabolic Rate: Stimulating lipid oxidation and energy expenditure directly within mature fat cells to study weight loss mechanisms independent of caloric restriction.
- Skeletal Muscle Stem Cell Regeneration: Evaluating muscle stem cell proliferation and myoblast maturation in aging or atrophy models through restored cellular energy dynamics.
Expected Research Results & Timeline Metrics
- Phase 1 / Days 1–7
Enzymatic Blockade & NAD+ Accumulation: Rapid inhibition of intracellular NNMT activity accompanied by measurable increases in cellular NAD+ levels in treated fat tissue assays. - Phase 2 / Weeks 2–4
Adipocyte Resizing & Oxygen Consumption: Statistically significant reduction in adipocyte volume (fat cell shrinkage), increased oxygen consumption rates (OCR), and elevated mitochondrial respiration. - Phase 3 / Weeks 4–8
Systemic Body Composition Shifts: Marked reduction in total adipose mass, improved insulin sensitivity parameters, and enhanced muscle fiber regeneration in diet-induced metabolic models.
Key Research Benefits
- Targeted Metabolic Pathway: Inhibits NNMT without interfering with other central metabolic enzymes or neurotransmitter systems.
- Dual Energy Booster: Simultaneously elevates NAD+ levels (powering sirtuins and mitochondria) and SAM levels (supporting epigenetic regulation).
- Direct Fat Cell Action: Reduces fat mass by decreasing fat cell size rather than causing cell death or relying on central nervous system appetite suppression.
- Regenerative Muscle Tool: Shows promising cross-disciplinary utility in age-related sarcopenia and muscle recovery research models.
THIS PRODUCT IS INTENDED SOLELY FOR IN VITRO LABORATORY RESEARCH AND EXPERIMENTAL PURPOSES. It is strictly prohibited for human consumption, clinical trials, therapeutic administration, cosmetic use, or veterinary application. This product is not an FDA-approved drug, medical food, or dietary supplement. It is not intended to diagnose, treat, cure, or prevent any disease, illness, or medical condition. Any handling, reconstitution, or experimentation involving this chemical compound must be conducted strictly by qualified, trained laboratory professionals utilizing appropriate containment and personal protective equipment in accordance with scientific biosafety standards. Buyers and users assume full liability for compliance with local, state, and federal laws regarding the handling and possession of research compounds.